Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2004-06-17 Regulatory Filings
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 registration statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes details about the stock option plan, the number of shares to be registered, legal opinions, consents from auditors and counsel, and signatures of company officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length (6675 characters) and content confirm it is a full registration statement, not a brief announcement or certification.
2004-06-17 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes details about the securities to be registered, the offering price, and the terms of the offering. The text includes a prospectus describing the company, its business, and the securities being offered. This is a capital markets filing related to fundraising and securities issuance, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, confirming it is not a mere announcement or regulatory filing. Confidence is high due to clear identification of the form and content.
2004-06-17 English
FORM 4 SUBMISSION
Director's Dealing
2004-05-24 English
FORM 4 SUBMISSION
Director's Dealing
2004-05-24 English
FORM 4 SUBMISSION
Director's Dealing
2004-05-24 English
FORM 4 SUBMISSION
Director's Dealing
2004-05-24 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.